Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1987-09-30
1990-05-01
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
530351, 435811, A61K 4502, C07K 1526, C12P 2100
Patent
active
049216988
ABSTRACT:
A polypeptide having gamma-interferon activity which lacks the amino acid sequence coded for by exon 4, a polynucleotide sequence which codes for said polypeptide, a replicable expression vehicle containing said polynucleotide sequence and a transformed microorganism containing said replicable expression vehicle are disclosed. The transformed microorganism is useful for preparing the polypeptide having gamma-interferon activity.
REFERENCES:
patent: 4604284 (1986-08-01), Kang et al.
Gray et al., Nature, vol. 295, pp. 503-508, 1982.
Davis et al., Nucleic Acid Research, vol. 10, pp. 2487-2500, 1982.
Yujiro Higashi et al., "The Third Annual International Congress for Interferon Research", Miami, Fla., Nov. 1-3, 1982.
Capon et al., "The Third Annual International Congress for Interferon Research", Miami, Fla., Nov. 1-3, 1982.
Shirai Takashi
Wallace R. Bruce
Asahi Kasei Kogyo Kabushiki Kaisha
Hazel Blondel
LandOfFree
Polypeptide having gamma-interferon activity lacking amino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide having gamma-interferon activity lacking amino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide having gamma-interferon activity lacking amino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-828536